Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.

In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report" by Global ...

NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum ...

WHO includes ArkBio' paediatric RSV drug, ziresovir in PADO-RSV priority list: Shanghai, China Thursday, July 17, 2025, 14:00 Hrs [IST] Shanghai Ark Biopharmaceutical Co., Ltd. (A ...

Common cold coronavirus incidence decreased by more than half after widespread SARS-CoV-2 infections and vaccination compared ...

Multinational pharmaceutical company, MSD has renewed its commitment to strengthening healthcare access in Nigeria, calling ...

Viruses and bacteria are always trying to sneak into our bodies, but researchers at the University of Missouri are ...

PATH has launched the largest study of its kind in Africa, recruiting 9,000 participants to test whether AI can help primary ...

Nigeria carries the highest burden of cervical cancer in Africa and ranks seventh globally, with an estimated 12,000 new cases and over 8,000 cervical cancer-related deaths annually, according to the ...

The update covers the safety and appropriate timing of vaccinations, screening for osteoporosis, cervical cancer, skin cancer ...